Updated GRACE ACS Risk and Mortality Calculator

The GRACE (and GRACE 2.0) risk score is a well-validated, internationally derived prognostic model for mortality after acute coronary syndrome (ACS). Its primary strengths are large multicenter derivation, consistent discrimination, and the extension in GRACE 2.0 to non-linear modeling and 1–3-year mortality estimates. However, the potential calibration drift over time and across health systems, under- or over-estimation in older/frail patients, and omission of social determinants (socioeconomic deprivation) and frailty which independently affect outcomes are some of the important limitations of the tool. For safe local use, clinicians should consider confirming external validation and calibration in their own setting. They should also be cautious applying the score where data elements are missing or when doing time-sensitive interventions (do not delay reperfusion).

Publication Details

Journal
Evidence to Action Official Journal of MDCalc
Published
2025-10-28
DOI
https://doi.org/10.65357/001c.145098
Primary Topic
Acute Myocardial Infarction Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Updated GRACE ACS Risk and Mortality Calculator

Evidence to Action Official Journal of MDCalc
Acute Myocardial Infarction Research
article

Updated GRACE ACS Risk and Mortality Calculator

article en

Abstract

The GRACE (and GRACE 2.0) risk score is a well-validated, internationally derived prognostic model for mortality after acute coronary syndrome (ACS). Its primary strengths are large multicenter derivation, consistent discrimination, and the extension in GRACE 2.0 to non-linear modeling and 1–3-year mortality estimates. However, the potential calibration drift over time and across health systems, under- or over-estimation in older/frail patients, and omission of social determinants (socioeconomic deprivation) and frailty which independently affect outcomes are some of the important limitations of the tool. For safe local use, clinicians should consider confirming external validation and calibration in their own setting. They should also be cautious applying the score where data elements are missing or when doing time-sensitive interventions (do not delay reperfusion).

Evidence to Action Official Journal of MDCalcVol. 042025(01)
Reduced inequalities
Openalex Percentile: Top 35%
Acute Myocardial Infarction Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.